OXAGEN

Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.
OXAGEN
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
1997-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxagen.co.uk
Total Employee:
51+
Status:
Active
Contact:
44 12 3584 1561
Email Addresses:
[email protected]
Total Funding:
130.74 M USD
Technology used in webpage:
SPF Nginx Microsoft Exchange Online Office 365 Mail Fasthosts DNS Fasthosts
Similar Organizations
Current Advisors List
Current Employees Featured
Founder
Investors List
Abingworth
Abingworth investment in Series C - Oxagen
MPM Capital
MPM Capital investment in Series C - Oxagen
Novartis Venture Fund
Novartis Venture Fund investment in Series C - Oxagen
International Biotechnology Trust
International Biotechnology Trust investment in Series C - Oxagen
Advent Venture Partners
Advent Venture Partners investment in Series C - Oxagen
Red Abbey Venture Partners
Red Abbey Venture Partners investment in Series C - Oxagen
Omega Funds
Omega Funds investment in Series C - Oxagen
SV Health Investors
SV Health Investors investment in Series C - Oxagen
Bessemer Venture Partners
Bessemer Venture Partners investment in Series C - Oxagen
Wellcome Trust
Wellcome Trust investment in Series C - Oxagen
Official Site Inspections
http://www.oxagen.co.uk
- Host name: 104.247.81.53
- IP address: 104.247.81.53
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto

More informations about "Oxagen"
OXAGEN LIMITED overview - Find and update company โฆ
Charges for OXAGEN LIMITED (03246469) Insolvency for OXAGEN LIMITED (03246469) More for OXAGEN LIMITED (03246469) Registered office address C/O CORK GULLY LLP, 6 Snow โฆSee details»
Oxagen 2025 Company Profile: Valuation, Funding & Investors
Oxagen General Information Description. Developer of small molecule drugs designed to treat inflammatory and respiratory diseases. The company's drugs comprise an oral anti โฆSee details»
Oxagen - VentureRadar
Oxagen Limited is a privately held UK biopharmaceutical company developing a pipeline of novel small molecule drugs addressing asthma and other chronic allergic and inflammatory โฆSee details»
Oxagen Company Profile | Management and Employees List
Oxagen is a biopharmaceutical company building a novel drug pipeline based on targets validated in man through its genetics platform. The Company specialises in target identification and โฆSee details»
Oxagen - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 26, 2025 Oxagen has raised a total funding of $86.5M over 2 rounds. Its first funding round was on May 23, 2005. Its latest funding round was a Series C round on Nov 24, 2009 for โฆSee details»
Oxagen Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Oxagen Ltd. with its drug pipeline, therapeutic area, technology platform, 11 clinical trials, 2 news, and 30 literature, Drug:Timapiprant, ATX-2286. ... The statistics for drugs in the โฆSee details»
Oxagen Company Profile - Office Locations, Competitors, Revenue โฆ
Oxagen has 5 employees at their 1 location, $130.65 m in total funding, and £24.18 k in annual revenue in FY 2015. See insights on Oxagen including office locations, competitors, revenue, โฆSee details»
Oxagen Limited: Contact Details and Business Profile - RocketReach
Oxagen is a biopharmaceutical company building a novel drug pipeline based on targets validated in man through its genetics platform. The Company specialises in target identification and โฆSee details»
Oxagen Ltd. - BioCentury Company Profiles - BCIQ
Oxagen Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Oxagen Limited Raises £16 Million in Series C Private ... - BioSpace
Nov 24, 2009 About Oxagen Oxagen is a biopharmaceutical company building a novel drug pipeline with a focus on inflammatory and respiratory diseases. Oxagenโs pipeline of novel โฆSee details»
Oxagen Becomes First UK Genomics Co - Pharmaceutical industry โฆ
Sep 24, 1997 Oxagen, the UK's first genomics company, has been established atAbingdon, near Oxford, England, by a group of former executives from British Biotech. James Noble, former โฆSee details»
Oxagen | VentureRadar
Oxagen Limited is a privately held UK biopharmaceutical company developing a pipeline of novel small molecule drugs addressing asthma and other chronic allergic and inflammatory โฆSee details»
Oxagen Ltd - Company Profile and News - Bloomberg Markets
Company profile page for Oxagen Ltd including stock price, company news, executives, board members, and contact informationSee details»
OXAGEN LIMITED - Companies House
OXAGEN LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»
Oxagen company information, funding & investors | Dealroom.co
Oxagen, a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions. Here you'll find information about their funding, โฆSee details»
House of Lords - Science and Technology - Written Evidence
Memorandum by Oxagen Ltd Oxagen is a Clinical Genomics Company investigating the genetic basis of common human disease to discover new diagnostics and better targeted therapies. โฆSee details»
OXAGEN LIMITED people - Find and update company information
OXAGEN LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»
Bill Gates - Co-Founder @ Oxagen - Crunchbase Person Profile
John Bell, MA, DM, FRCP is Founder of Oxagen Limited. Bell co-founded Wellcome Trust Centre for Human Genetics at the University of Oxford. He serves as Development Advisory Board โฆSee details»
OXAGEN LIMITED insolvency - Find and update company โฆ
More for OXAGEN LIMITED (03246469) 1 Insolvency case. Case number 1 โ Members voluntary liquidation . Commencement of winding up 31 October 2022 Declaration of solvency โฆSee details»
Conservative Oxygen Therapy in Mechanically Ventilated Critically โฆ
5 days ago Several clinical trials have shown no difference in outcome between a conservative compared with a more liberal approach to oxygen therapy in critically ill patients. 4-8 However, โฆSee details»